237 related articles for article (PubMed ID: 36709212)
1. Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR.
Lecoq L; Brigandat L; Huber R; Fogeron ML; Wang S; Dujardin M; Briday M; Wiegand T; Callon M; Malär A; Durantel D; Burdette D; Berke JM; Meier BH; Nassal M; Böckmann A
Nat Commun; 2023 Jan; 14(1):471. PubMed ID: 36709212
[TBL] [Abstract][Full Text] [Related]
2. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
[TBL] [Abstract][Full Text] [Related]
3. The Mechanism of Action of Hepatitis B Virus Capsid Assembly Modulators Can Be Predicted from Binding to Early Assembly Intermediates.
Pavlova A; Bassit L; Cox BD; Korablyov M; Chipot C; Patel D; Lynch DL; Amblard F; Schinazi RF; Gumbart JC
J Med Chem; 2022 Mar; 65(6):4854-4864. PubMed ID: 35290049
[TBL] [Abstract][Full Text] [Related]
4. Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids.
Kim C; Barnes LF; Schlicksup CJ; Patterson AJ; Bothner B; Jarrold MF; Wang CJ; Zlotnick A
J Virol; 2022 Jan; 96(2):e0139521. PubMed ID: 34705562
[TBL] [Abstract][Full Text] [Related]
5. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
Ruan L; Hadden JA; Zlotnick A
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
[TBL] [Abstract][Full Text] [Related]
6. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators.
Luo Y; Cheng J; Hu Z; Ban H; Wu S; Hwang N; Kulp J; Li Y; Du Y; Chang J; Viswanathan U; Guo JT
Antiviral Res; 2021 Jul; 191():105080. PubMed ID: 33933516
[TBL] [Abstract][Full Text] [Related]
7. Energetics and Kinetic Assembly Pathways of Hepatitis B Virus Capsids in the Presence of Antivirals.
Kra K; Li S; Gargowitsch L; Degrouard J; Pérez J; Zandi R; Bressanelli S; Tresset G
ACS Nano; 2023 Jul; 17(13):12723-12733. PubMed ID: 37342963
[TBL] [Abstract][Full Text] [Related]
8. Biophysics-Guided Lead Discovery of HBV Capsid Assembly Modifiers.
Fan Z; Pavlova A; Jenkins MC; Bassit L; Salman M; Lynch DL; Patel D; Korablyov M; Finn MG; Schinazi RF; Gumbart JC
ACS Infect Dis; 2024 Apr; 10(4):1162-1173. PubMed ID: 38564659
[TBL] [Abstract][Full Text] [Related]
9. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
[TBL] [Abstract][Full Text] [Related]
10. Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.
Ludgate L; Liu K; Luckenbaugh L; Streck N; Eng S; Voitenleitner C; Delaney WE; Hu J
J Virol; 2016 Jun; 90(12):5830-5844. PubMed ID: 27076641
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.
Yin J; Feng Z; Li Z; Hu J; Hu Y; Cai X; Zhou H; Wang K; Tang N; Huang A; Huang L
Eur J Med Chem; 2023 Mar; 249():115141. PubMed ID: 36709646
[TBL] [Abstract][Full Text] [Related]
12. Diazepinone HBV capsid assembly modulators.
Kuduk SD; DeRatt LG; Stoops B; Shaffer P; Lam AM; Espiritu C; Vogel R; Lau V; Flores OA; Hartman GD
Bioorg Med Chem Lett; 2022 Sep; 72():128823. PubMed ID: 35644301
[TBL] [Abstract][Full Text] [Related]
13. Generation of an HBV core phenotyping assay for evaluating HBV capsid compounds.
Liu Y; Chang S; Hsieh D; Burdette D; Martin R; Mo H; Feierbach B
J Virol Methods; 2021 Jun; 292():114117. PubMed ID: 33657432
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
[TBL] [Abstract][Full Text] [Related]
15. Capsid Phosphorylation State and Hepadnavirus Virion Secretion.
Ning X; Basagoudanavar SH; Liu K; Luckenbaugh L; Wei D; Wang C; Wei B; Zhao Y; Yan T; Delaney W; Hu J
J Virol; 2017 May; 91(9):. PubMed ID: 28228589
[TBL] [Abstract][Full Text] [Related]
16. Di-fluoro azepane HBV capsid assembly modulators.
DeRatt LG; Stoops B; Shaffer P; Lam AM; Espiritu C; Vogel R; Lau V; Flores OA; Kuduk SD
Bioorg Med Chem Lett; 2023 Aug; 92():129350. PubMed ID: 37247697
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of HBV capsid assembly modulators.
Nijampatnam B; Liotta DC
Curr Opin Chem Biol; 2019 Jun; 50():73-79. PubMed ID: 30952041
[TBL] [Abstract][Full Text] [Related]
18. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
[TBL] [Abstract][Full Text] [Related]
20. CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging.
Wu S; Luo Y; Viswanathan U; Kulp J; Cheng J; Hu Z; Xu Q; Zhou Y; Gong GZ; Chang J; Li Y; Guo JT
Antiviral Res; 2018 Nov; 159():1-12. PubMed ID: 30201396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
